gitrl Search Results


93
Miltenyi Biotec anti gitrl
Anti Gitrl, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/GITRL+Antibody%2C+anti-human%2C+REAfinity/pmc06530055-78-72-74
Average 93 stars, based on 1 article reviews
anti gitrl - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech 1 ap
1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/TNFSF18+Antibody/pm40773347-324-182-180
Average 93 stars, based on 1 article reviews
1 ap - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology anti gitrl antibody
Anti Gitrl Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/GITRL+Antibody/pmc03055339-158-54-56
Average 92 stars, based on 1 article reviews
anti gitrl antibody - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

92
Bio-Rad rat anti mouse control monoclonal antibody
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Rat Anti Mouse Control Monoclonal Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/Rat+anti+Mouse+GITRL/pmc08443399-148-11-18
Average 92 stars, based on 1 article reviews
rat anti mouse control monoclonal antibody - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

93
BPS Bioscience tr fret assay kits
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Tr Fret Assay Kits, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/GITR%3AGITRL+TR-FRET+Assay+Kit/pm37666177-62-0-5
Average 93 stars, based on 1 article reviews
tr fret assay kits - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Apogenix Inc hexavalent gitr ligand fusion protein hera-gitrl
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Hexavalent Gitr Ligand Fusion Protein Hera Gitrl, supplied by Apogenix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/hexavalent+gitr+ligand+fusion+protein+hera+gitrl/pmc06220479-6906-13-2
Average 90 stars, based on 1 article reviews
hexavalent gitr ligand fusion protein hera-gitrl - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Enzo Biochem soluble gitrl
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Soluble Gitrl, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/soluble+gitrl/pm22911397-77-3-5
Average 90 stars, based on 1 article reviews
soluble gitrl - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GeneTex rabbit anti-gitrl primary antibody
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Rabbit Anti Gitrl Primary Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/rabbit+anti+gitrl/pmc07869253-51-1-6
Average 90 stars, based on 1 article reviews
rabbit anti-gitrl primary antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Apogenix Inc hera-gitrl
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Hera Gitrl, supplied by Apogenix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/hera+gitrl/pmc06220479-6906-22-2
Average 90 stars, based on 1 article reviews
hera-gitrl - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
clea japan inc ecorv-mouse gitrl-bglii
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Ecorv Mouse Gitrl Bglii, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/ecorv+mouse+gitrl+bglii/us09144603-148-0-13
Average 90 stars, based on 1 article reviews
ecorv-mouse gitrl-bglii - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
MedImmune llc mouse gitr ligand fusion protein (gitrl fp)
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Mouse Gitr Ligand Fusion Protein (Gitrl Fp), supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/mouse+gitr+ligand+fusion+protein++gitrl+fp+/pmc04674486-46-7-23
Average 90 stars, based on 1 article reviews
mouse gitr ligand fusion protein (gitrl fp) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Verlag GmbH gitrl-rpe
CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse <t>monoclonal</t> antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.
Gitrl Rpe, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gitrl/gitrl+rpe/pm16874737-106-9-21
Average 90 stars, based on 1 article reviews
gitrl-rpe - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse monoclonal antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.

Journal: Platelets

Article Title: Lymphatic blood filling in CLEC-2-deficient mouse models

doi: 10.1080/09537104.2020.1734784

Figure Lengend Snippet: CLEC-2 deficiency during chronic, but not acute, dermal vascular remodeling can lead to localized lymphatic vessel blood filling. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls were subjected to cutaneous reverse passive Arthus reaction (rpA) and skin biopsies were collected 4 h after reaction initiation. In neither genotype could blood-filled lymphatic vessels be identified by gross or microscopic assessment. (Ai) Representative images of rpA-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls. (Aii) Representative images of rpA-challenged skin sections from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls stained for podoplanin (brown) and hematoxylin (blue). Lymphatic vessels indicated by yellow arrows. Scale bar = 100 μm. Wildtype mice rendered thrombocytopenic by treatment of 2 μg/g of anti-GpIba rat anti-mouse monoclonal antibody mixture (R300) 18 h before rpA initiation had red blood cells in lymphatic vessels upon microscopic inspection. (Bi) Representative images of non-inflamed and inflamed areas of rpA-challenged skin sections from thrombocytopenic wildtype mice stained for podoplanin (brown) and hematoxylin (blue) and red blood cells (yellow). Lymphatic vessels indicated by yellow arrows. Scale bar = 50 μm. n = 4. (Bii) Quantification of the presence of red blood cells in podoplanin positive lymphatic vessels in rpA-challenged skin sections from thrombocytopenic wildtype mice. Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls received an intradermal injection of B16F10 melanoma cells into back skin. After 12 days of tumor growth, skin was harvested. (C) Representative images of melanoma-challenged skin from Pf4-Cre CLEC-2 deficient mice and littermate wildtype controls and quantification of blood-filled tumor-associated lymphatic vessels (yellow arrows) in Pf4-Cre CLEC-2 deficient mice. n = 10.

Article Snippet: Anti-CLEC-2 rat anti-mouse monoclonal antibody (17D9, used for flow cytometry) and rat anti-mouse control monoclonal antibody were from BioRad.

Techniques: Staining, Injection